3,4,5-trimethoxycinnamic acid has been researched along with Benign Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
Bagchi, R; Islam, MT; Khalipha, ABR; Mondal, M; Rouf, R; Shilpi, JA; Smrity, SZ; Uddin, SJ | 1 |
2 review(s) available for 3,4,5-trimethoxycinnamic acid and Benign Neoplasms
Article | Year |
---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Anticancer activity of thymol: A literature-based review and docking study with Emphasis on its anticancer mechanisms.
Topics: Animals; Anticarcinogenic Agents; Cell Proliferation; Cinnamates; Humans; Mice; Molecular Docking Simulation; Neoplasms; Poly (ADP-Ribose) Polymerase-1; Protein Kinase C; Rats; Thymol | 2019 |